Occidental Petroleum
OXY
The Kraft Heinz
KHC
VeriSign
VRSN
4
Visa
V
5
Chubb Ltd
CB
US Stock MarketDetailed Quotes
VYNE VYNE Therapeutics
- 2.5000
- +0.0300+1.21%
Close Feb 18 16:00 ET
36.88MMarket Cap0.74P/E (TTM)
2.5572High2.3900Low50.18KVolume2.4600Open2.4700Pre Close124.31KTurnover0.50%Turnover RatioLossP/E (Static)14.75MShares4.300052wk High0.58P/B25.29MFloat Cap1.570052wk Low--Dividend TTM10.12MShs Float2869.9200Historical High--Div YieldTTM6.77%Amplitude1.5700Historical Low2.4770Avg Price1Lot Size
VYNE Therapeutics Key Stats
EPS
According to the latest financial report of VYNE Therapeutics, the latest earnings per share (TTM) for the company is -0.29. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about VYNE Therapeutics's free cash flow? The latest report shows it as -8.51M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of VYNE Therapeutics shows that the company's current ratio is 5.81, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of VYNE Therapeutics, the quick ratio is 5.54, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of VYNE Therapeutics? The latest ROE figure is -17.57%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of VYNE Therapeutics, the total asset return on investment (ROA) is -14.93%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check VYNE Therapeutics's latest financial report to see how their gross margin is doing - currently at 87.54%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of VYNE Therapeutics, the net profit margin is -10.05K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now